FDA — authorised 30 September 2003
- Application: NDA021450
- Marketing authorisation holder: AMNEAL
- Local brand name: ZOMIG
- Indication: SPRAY — NASAL
- Status: approved
FDA authorised Rapimelt on 30 September 2003
Yes. FDA authorised it on 30 September 2003.
AMNEAL holds the US marketing authorisation.